Intelligence · Clinical Development
Pipeline search results
Programs matching “acute-myeloid-leukemia” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 134 pipeline programs matching "acute-myeloid-leukemia" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
APR-246
Aprea Therapeutics
Acute Myeloid Leukemia or Myelodysplastic Syndromes
1 trial -
Alisertib
Takeda
Acute Myeloid Leukemia
1 trial -
Ara-C Group
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
BGB-11417
BEONE MEDICINES AUS PTY LTD
Acute Myeloid Leukemia
1 trial -
CD123 targeted CAR-NK cells
Chongqing Precision Biotech Co., Ltd
Acute Myeloid Leukemia
1 trial -
CEP-701
Teva Pharma GmbH
Acute Myeloid Leukemia
1 trial -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia (AML) in Remission
1 trial -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia (AML)
2 trials -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
7 trials -
Clifutinib Besylate
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Acute Myeloid Leukemia, Adult
1 trial -
Cytarabine
Kura Oncology
Acute Myeloid Leukemia
1 trial -
Cytarabine
Teva Pharma GmbH
Acute Myeloid Leukemia
1 trial -
Cytarabine and Idarubicin
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
Decitabine
CATALYST PHARMACEUTICALS, INC.
Acute Myeloid Leukemia
1 trial -
Decitabine
Shanghai Tong Ren Hospital
Acute Myeloid Leukemia
1 trial -
Decitabine
The University of Hong Kong
Acute Myeloid Leukemia
1 trial -
Decitabine
Teva Pharma GmbH
Acute Myeloid Leukemia
1 trial -
Dociparstat sodium
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
Enasidenib Mesylate
Jazz Pharmaceuticals Ireland Limited
Recurrent Acute Myeloid Leukemia
1 trial -
Fludarabine
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia, Adult
1 trial -
GTI-2040
Aptose Biosciences
Acute Myeloid Leukemia
1 trial -
GVA + HDAC Consolidation & Gilteritinib Maintenance
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Group A (FIT): Avapritinib + IA regimen
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
1 trial -
Ivosidenib combined with venetoclax and azacitidine
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.